you are here: HomeNewscoronavirus

COVID-19 vaccination | No glitch in CoWIN from the start: RS Sharma

RS Sharma calrified that the registration for COVID-19 vaccination is taking place only through Aarogya Setu app and Co-WIN’s portal

March 01, 2021 / 09:07 PM IST
RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN).

RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN).

Dismissing the "rumours" of technical glitches in Co-WIN platform, RS Sharma, Chairman of Empowered Group on Vaccine Administration (Co-WIN), on March 1 said the confusion was created by spreading misinformation that vaccination registration is being done through a mobile application.

There were rumours that people who want to book an appointment for COVID-19 vaccination should register on Co-WIN app instead of Co-WIN website.

The National Heath Authority CEO clarified that the registration for vaccine is taking place only through Aarogya Setu app and Co-WIN’s portal

Speaking to ANI, Sharma said ,"There has been no glitch right from the start. What happened was that some people spread the misinformation that there is a Co-WIN app. So, people started searching for the app which is not ours. That is why there was some confusion among the people. After clarifying there is no Co-WIN app, we have given an extension in Aarogya Setu app for registration and provided a portal ‘’.

As the second phase of nationwide vaccination drive against the coronavirus disease started on March 1, 17 lakh people have registered for the vaccination against COVID-19 so far since the morning. This system is working fine and there is no glitch, he said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The former Telecom Regulatory Authority of India (TRAI) chief also hailed Prime Minister Narendra Modi, who received the first jab of Covaxin at AIIMS, Delhi, adding that this will give a strong message to reduce the vaccine hesitancy among people.

“Vaccine hesitancy is a social perspective. But today, Prime Minister Narendra Modi took the jab on the first day itself is a big message and people will be encouraged for taking the vaccine. Gradually, it will end the vaccine hesitancy,” he said.

On certificate given to people after taking vaccination, he said, “We have given the instruction to all, whether private or public, that as soon as a vaccination is completed, a certificate must be given to the person on the spot. That certificate will also be made available digitally as well on Aarogya Setu.”

“They can download the link and get it printed as well. This will be a digitally signed certificate. After every vaccination, a certificate will be issued. After first vaccination, a provisional certificate will be provided and a final certificate will be issued after the second dose,” he added.

Responding to data privacy and safety, he said, “Data privacy is also important for us and it is a fundamental right. We are just asking for name, gender and age related data. It is not extremely sensitive data. This is important for us so that person who gets a particular vaccine should get the same vaccine in the second dose as well. Whatever data we have are safe.”

Those who could not attend the scheduled vaccination drive can reschedule, cancel, or take reappointment for the same.

Sharma also said digital and paperless authentication is possible only through Aadhar Card. If a person brings Aadhar, he or she does not need to bring a hardcopy. In case of driving license, passport and other ID proofs, photograph of the document will be taken along with photo of the person, reported ANI.

The second phase of the nationwide COVID-19 vaccination drive for age-appropriate population groups (people above 60 and those with comorbidities above 45) began on Monday with the Union Health Ministry calling out eligible people to get an appointment at respective hospitals in the country.

With inputs from ANI
Moneycontrol News

stay updated

Get Daily News on your Browser